Pharmasset Inc. (VRUS) Stock Quote

Stock Web

Detailed Quote for Pharmasset Inc. (VRUS)

close 52 Week Information

52 Week High

June 17,2010

Close: 33.90

52 Week Low

September 02,2009

Close: 18.24

Today

5d

1m

3m

1y

more

Last Price
24.76

Change $
0.10

Change %
0.41%

Tick

Bid
24.71

Bid Size
100

Ask
24.79

Ask Size
200

Open
24.73

High
25.22

Low
24.66

Prev Close
24.66

Last Trade
10:51

Volume
13.71 k

52 Wk Hi
33.90

52 Wk Low
18.24

Market Cap
841.46 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
33,984,692

EPS (TTM)
-2.06

PE Ratio
N/A

close Exchange Information Listed On NASDAQ (NSD) Exchange
NSD

News and Media for Pharmasset Inc. (VRUS)

Sector News | Topic News

News for VRUS

Tue, Aug 24, 2010

6:50 AM

Pharmasset Initiates Phase 2b Clinical Trial of PSI-7977 for Chronic Hepatitis C Genotypes 1, 2, and 3 - PR Newswire

Thu, Aug 12, 2010

7:00 AM

PSI-7977 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection - PR Newswire

Mon, Aug 09, 2010

4:15 PM

Pharmasset Reports Fiscal Third Quarter 2010 Financial Results - PR Newswire

Fri, Jul 30, 2010

4:30 PM

Pharmasset to Present at Two Upcoming Investor Conferences - PR Newswire

Wed, Jul 28, 2010

6:45 AM

Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-938 in Patients with Chronic Hepatitis C - PR Newswire

Wed, Jun 09, 2010

6:51 AM

Pharmasset Announces Submission of Abstracts to AASLD Liver Meeting Including an Interim Analysis of Roche's Phase 2b PROPEL Trial of RG7128 - PR Newswire

Mon, Jun 07, 2010

7:00 AM

Pharmasset to Present at Two Upcoming Investor Conferences - PR Newswire

Thu, May 20, 2010

4:00 PM

Pharmasset to Present at the Citi Global Healthcare Conference - PR Newswire

Tue, May 18, 2010

7:01 AM

Pharmasset Announces Exercise of Underwriters' Overallotment Option - PR Newswire

Thu, May 13, 2010

9:45 PM

Pharmasset Prices Public Offering of Common Stock - PR Newswire

Tue, May 11, 2010

4:02 PM

Pharmasset Announces Proposed Public Offering of Common Stock - PR Newswire

Wed, May 05, 2010

5:28 PM

Pharmasset Reports Fiscal Second Quarter 2010 Financial Results - PR Newswire

Tue, May 04, 2010

7:39 AM

Pharmasset Affirms Safety and Continued Progress in Clinical Development of RG7128 - PR Newswire

7:04 AM

Pharmasset Announces Results of a 28-day Phase 2a Study with PSI-7977 for the Treatment of Chronic Hepatitis C Infection - PR Newswire

Fri, Apr 30, 2010

7:01 AM

Pharmasset to Present at the Bank of America Merrill Lynch Health Care Conference - PR Newswire

Thu, Apr 15, 2010

4:42 AM

Pharmasset Announces Interim Data from an Ongoing 28-day Phase 2a Study with PSI-7977 for the Treatment of Chronic Hepatitis C Infection - PR Newswire

Tue, Apr 13, 2010

7:33 AM

Pharmasset to Present New Data on RG7128 and PSI-7977 at the EASL Conference - PR Newswire

Thu, Apr 08, 2010

7:30 AM

Pharmasset Initiates First Time in Human Study of PSI-938 for the Treatment of Hepatitis C - PR Newswire

Mon, Mar 29, 2010

4:00 PM

Pharmasset to Present at the Canaccord Adams Hepatitis C Conference - PR Newswire

Fri, May 09, 2008

8:00 PM

Semi-Annual Changes to the NASDAQ Biotechnology Index - Globe Newswire

More News for VRUS >>

Tags for Pharmasset Inc.

Research stocks or mutual funds related to Pharmasset Inc. by keywords or tags. Find companies that have a similar focus to VRUS. The keywords below have been associated to VRUS by either user submission or electronic means.

biotechnology company stock trading financial ratio analysis corporate financial starbucks stock information map chest financial annual report laminated world map corporate secretary software annual report pharmaceutical supplies corporate governance investor relations service pharmaceuticals jobs pharma license pepsi stock symbol novartis pharmaceuticals financial report corporate travel center pharmaceutical class stock report investor relations data map anaheim hotel board of directors role pharmaceutical sales pharma stock returns world map posters biotech corporation minsk street map Drugs annual report of company corporate annual report investor relations information pepsi stock stock market report financial stock report board of directors info starbucks stock symbol pharmaceutical article pfizer pharmaceuticals pepsi annual report pharmaceutical events biotech investment board of directors responsibility pharmaceutical sale pharmaceutical business development Healthcare oil and gas investments bio pharmaceuticals

Bookmark With:

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.